Targeting regulated cell death (RCD) with small-molecule compounds in triple-negative breast cancer: a revisited perspective from molecular mechanisms to targeted …

M Liao, R Qin, W Huang, HP Zhu, F Peng… - Journal of Hematology & …, 2022 - Springer
Triple-negative breast cancer (TNBC) is a subtype of human breast cancer with one of the
worst prognoses, with no targeted therapeutic strategies currently available. Regulated cell …

Aberrant sialylation in cancer: therapeutic opportunities

J Munkley - Cancers, 2022 - mdpi.com
Simple Summary All cells are covered in a thick layer of sugar molecules known as glycans.
Changes to this sugar coat are common in cancer, and in particular cancer cells often …

[HTML][HTML] Targeting breast cancer stem cells

L Zhang, W Chen, S Liu, C Chen - International journal of …, 2023 - ncbi.nlm.nih.gov
The potential roles of breast cancer stem cells (BCSCs) in tumor initiation and recurrence
have been recognized for many decades. Due to their strong capacity for self-renewal and …

[HTML][HTML] CAR-T cell therapy for breast cancer: from basic research to clinical application

YH Yang, JW Liu, C Lu, JF Wei - International journal of biological …, 2022 - ncbi.nlm.nih.gov
Breast cancer rises as the most commonly diagnosed cancer in 2020. Among women,
breast cancer ranks first in both cancer incidence rate and mortality. Treatment resistance …

PI3K/Akt/mTOR signaling pathway in cancer stem cells

M Ebrahimi, E Nourbakhsh, AZ Hazara… - … -Research and Practice, 2022 - Elsevier
Cancer stem cells (CSCs) as a small subpopulation in tumor bulk are believed to initiate
tumor formation and are responsible for the resistance to cancer therapy. The proliferation …

Aberrant sialylation in cancer: biomarker and potential target for therapeutic intervention?

S Pietrobono, B Stecca - Cancers, 2021 - mdpi.com
Simple Summary Sialylation is a post-translational modification that consists in the addition
of sialic acid to growing glycan chains on glycoproteins and glycolipids. Aberrant sialylation …

Focal Adhesion Kinase (FAK)-Hippo/YAP transduction signaling mediates the stimulatory effects exerted by S100A8/A9-RAGE system in triple-negative breast cancer …

DC Rigiracciolo, N Nohata, R Lappano, F Cirillo… - Journal of Experimental …, 2022 - Springer
Background Understanding the intricate signaling network involved in triple-negative breast
cancer (TNBC) represents a challenge for developing novel therapeutic approaches. Here …

Glycosphingolipids are mediators of cancer plasticity through independent signaling pathways

C Cumin, YL Huang, C Rossdam, F Ruoff… - Cell Reports, 2022 - cell.com
The molecular repertoire promoting cancer cell plasticity is not fully elucidated. Here, we
propose that glycosphingolipids (GSLs), specifically the globo and ganglio series, correlate …

Glycosylation and its implications in breast cancer

DA Scott, RR Drake - Expert review of proteomics, 2019 - Taylor & Francis
Introduction: For decades, the role of glycans and glycoproteins in the progression of breast
cancer and other cancers have been evaluated. Through extensive studies focused on …

The biological role and immunotherapy of gangliosides and GD3 synthase in cancers

S Cao, X Hu, S Ren, Y Wang, Y Shao, K Wu… - Frontiers in Cell and …, 2023 - frontiersin.org
Gangliosides are a large subfamily of glycosphingolipids that broadly exist in the nervous
system and interact with signaling molecules in the lipid rafts. GD3 and GD2 are two types of …